Proteomic profiling of serum from patients with tuberculosis

Annals of Laboratory Medicine

Volumn 34, Issue 5, 2014, Pages 345-353

  Song, Sang Hoon ^a,b   Han, Minje ^a,b   Choi, Yang Seon ^a   Dan, Ki Soon ^a   Yang, Man Gil ^a   Song, Junghan ^c   Park, Sung Sup ^a,b   Lee, Jae Ho ^c  

^a Biomedical Research Institute   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Alpha 1 antitrypsin; Proteomics; Tuberculosis

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTITHROMBIN III; BIOLOGICAL MARKER; PROTEOME;

ADULT; AGED; BLOOD; DISCRIMINANT ANALYSIS; FEMALE; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEOMICS; TUBERCULOSIS;

ADULT; AGED; ALPHA 1-ANTITRYPSIN; ANTITHROMBIN III; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUBERCULOSIS;

EID: 84907403680     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2014.34.5.345     Document Type: Article

References (27)

1. Wayne LG and Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev 1992;5:1-25.
2. Neonakis IK, Gitti Z, Krambovitis E, Spandidos DA. Molecular diagnostic tools in mycobacteriology. J Microbiol Methods 2008;75:1-11.
3. Zhang Z and Chan DW. The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers. Cancer Epidemiol Biomarkers Prev 2010;19:2995-9.
4. Boja ES and Rodriguez H. The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science. Korean J Lab Med 2011;31:61-71.
5. Cheng FY, Blackburn K, Lin YM, Goshe MB, Williamson JD. Absolute protein quantification by LC/MS(E) for global analysis of salicylic acid-induced plant protein secretion responses. J Proteome Res 2009;8:82-93.
6. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010;375:1920-37.
7. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006;368:1012-21.
8. Wong CT and Saha N. Changes in serum proteins (albumin, immunoglobulins and acute phase proteins) in pulmonary tuberculosis during therapy. Tubercle 1990;71:193-7.
9. Emmett M, Miller JL, Crowle AJ. Protein abnormalities in adult respiratory distress syndrome, tuberculosis, and cystic fibrosis sera. Proc Soc Exp Biol Med 1987;184:74-82.
10. Grange JM, Kardjito T, Setiabudi I. A study of acute-phase reactant proteins in Indonesian patients with pulmonary tuberculosis. Tubercle 1984;65:23-39.
11. Schaller J, Gerber S, et al. eds. Human blood plasma proteins:structure and function. Chichester, West Sussex: John Wiley & Sons, 2008.
12. Laurell CB and Eriksson S. The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. COPD 2013;10(S1):S3-8.
13. Lisowska-Myjak B. AAT as a diagnostic tool. Clin Chim Acta 2005; 352:1-13.
14. Miravitlles M. Alpha-1-antitrypsin and other proteinase inhibitors. Curr Opin Pharmacol 2012;12:309-14.
15. Cylwik B, Chrostek L, Gindzienska-Sieskiewicz E, Sierakowski S, Szmitkowski M. Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis. Adv Med Sci 2010;55:80-5.
16. Wu W, Juan WC, Liang CR, Yeoh KG, So J, Chung MC. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Proteomics Clin Appl 2012;6:152-62.
17. Morgan BP. Regulation of the complement membrane attack pathway. Crit Rev Immunol 1999;19:173-98.
18. Sai Baba KS, Moudgil KD, Jain RC, Srivastava LM. Complement activation in pulmonary tuberculosis. Tubercle 1990;71:103-7.
19. Turken O, Kunter E, Sezer M, Solmazgul E, Cerrahoglu K, Bozkanat E, et al. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2002;6:927-32.
20. Robson SC, White NW, Aronson I, Woollgar R, Goodman H, Jacobs P. Acute-phase response and the hypercoagulable state in pulmonary tuberculosis. Br J Haematol 1996;93:943-9.
21. Kozakiewicz L, Phuah J, Flynn J, Chan J. The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Adv Exp Med Biol 2013;783:225-50.
22. Kirwan GM, Johansson E, Kleemann R, Verheij ER, Wheelock AM, Goto S, et al. Building multivariate systems biology models. Anal Chem 2012;84:7064-71.
23. Fan L, Zhang W, Yin M, Zhang T, Wu X, Zhang H, et al. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform. Acta Oncol 2012;51:473-9.
24. Liu Y, Sun X, Di D, Quan J, Zhang J, Yang X. A metabolic profiling analysis of symptomatic gout in human serum and urine using high performance liquid chromatography-diode array detector technique. Clin Chim Acta 2011;412:2132-40.
25. Wang X, Zhang A, Han Y, Wang P, Sun H, Song G, et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 2012;11:370-80.
26. Li Y, Zhou K, Zhang Z, Sun L, Yang J, Zhang M, et al. Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia. Mol Biosyst 2012;8:2664-71.
27. Ray S, Renu D, Srivastava R, Gollapalli K, Taur S, Jhaveri T, et al. Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. PLoS One 2012;7:e41751.